BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25845598)

  • 1. A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation.
    Hatano K; Kumar B; Zhang Y; Coulter JB; Hedayati M; Mears B; Ni X; Kudrolli TA; Chowdhury WH; Rodriguez R; DeWeese TL; Lupold SE
    Nucleic Acids Res; 2015 Apr; 43(8):4075-86. PubMed ID: 25845598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation.
    Metheetrairut C; Adams BD; Nallur S; Weidhaas JB; Slack FJ
    Oncogene; 2017 Jan; 36(4):512-524. PubMed ID: 27321180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity.
    Girardi C; De Pittà C; Casara S; Sales G; Lanfranchi G; Celotti L; Mognato M
    PLoS One; 2012; 7(2):e31293. PubMed ID: 22347458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-99 family regulates the DNA damage response through its target SNF2H.
    Mueller AC; Sun D; Dutta A
    Oncogene; 2013 Feb; 32(9):1164-72. PubMed ID: 22525276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation.
    Chen S; Srinivasan G; Jaiswal A; Williamson EA; Li L; Arris D; Zhou D; Xu M; Hromas R
    Exp Hematol; 2024 Jan; 129():104123. PubMed ID: 37875176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Dependent Transcriptional Response to Ionizing Radiation Is Orchestrated with DNA Repair within the Nuclear Space.
    Chaturvedi G; Sarusi-Portuguez A; Loza O; Shimoni-Sebag A; Yoron O; Lawrence YR; Zach L; Hakim O
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactome of Radiation-Induced microRNA-Predicted Target Genes.
    Lhakhang TW; Chaudhry MA
    Comp Funct Genomics; 2012; 2012():569731. PubMed ID: 22924026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic roadmap to the response to genotoxic agents in human cells.
    Ciccia A; Greenberg RA; Lees-Miller SP; Nussenzweig A
    Fac Rev; 2022; 11():35. PubMed ID: 36532708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REV7/MAD2L2: the multitasking maestro emerges as a barrier to recombination.
    Sale JE
    EMBO J; 2015 Jun; 34(12):1609-11. PubMed ID: 25896508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer-siRNA Chimeras in Human Tumor Xenografts.
    Ni X; Zhang Y; Zennami K; Castanares M; Mukherjee A; Raval RR; Zhou H; DeWeese TL; Lupold SE
    Mol Cancer Ther; 2015 Dec; 14(12):2797-804. PubMed ID: 26438155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilization of pluripotency in the absence of Mad2l2.
    Pirouz M; Rahjouei A; Shamsi F; Eckermann KN; Salinas-Riester G; Pommerenke C; Kessel M
    Cell Cycle; 2015; 14(10):1596-610. PubMed ID: 25928475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
    Segal CV; Koufaris C; Powell C; Gooderham NJ
    Toxicology; 2015 Jul; 333():45-52. PubMed ID: 25846647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B; Lupold SE
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.
    Szabo Z; Mena E; Rowe SP; Plyku D; Nidal R; Eisenberger MA; Antonarakis ES; Fan H; Dannals RF; Chen Y; Mease RC; Vranesic M; Bhatnagar A; Sgouros G; Cho SY; Pomper MG
    Mol Imaging Biol; 2015 Aug; 17(4):565-74. PubMed ID: 25896814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
    Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
    Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition.
    El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
    Gong P; Zhang T; He D; Hsieh JT
    Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy Metastatic Prostate Cancer Cell Lines Treated with Gold Nanorods Modulate miRNA Signatures.
    Soares S; Aires F; Monteiro A; Pinto G; Faria I; Sales G; Correa-Duarte MA; Guerreiro S; Fernandes R
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway.
    Jiang T; Chen J; Wang Z; Wang X; Ma J; Zhao F; Huang C; Chen Y
    Breast Cancer; 2023 Sep; 30(5):691-702. PubMed ID: 37460775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.